PGHL — Procter & Gamble Health Share Price
0.000.00%
Last trade - 00:00- IN₹86.71bn
- IN₹83.93bn
- IN₹11.51bn
- 100
- 19
- 91
- 83
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 33.32 | ||
| PEG Ratio (f) | 3.26 | ||
| EPS Growth (f) | 11.38% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 14.2 | ||
| Price to Tang. Book | 14.22 | ||
| Price to Free Cashflow | 33.21 | ||
| Price to Sales | 7.48 | ||
| EV to EBITDA | 25.21 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 47.31% | ||
| Return on Equity | 33.41% | ||
| Operating Margin | 26.53% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 13,558.6 | 10,087.3 | 11,144.1 | 12,296.2 | 11,512.6 | 12,546 | 13,536 | 6.28% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +164.28 | -30.78 | +11.23 | +20.38 | -8.35 | +8.98 | +11.89 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Directors
- Suresh Talwar NEC (83)
- Amit Gupta CFO
- Zeal Shah CCO
- Vikas Gupta GCN
- Milind Thatte MDR
- Anand Nambiar DRC (43)
- Aalok Agrawal NED
- Hon Keong Choo NED
- Elizabeth Desmond NED
- Bradley Simpson NED
- Zoe Tang NED
- Rani Jadhav IND (66)
- H. C. H. Bhabha NID (59)
- C. R. Dua NID
- Subramanian Madhavan NID
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 26th, 1967
- Public Since
- November 21st, 1993
- No. of Shareholders
- 57,524
- No. of Employees
- 1,336
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 16,599,382
- Address
- Godrej One,, MUMBAI, 400099
- Web
- https://www.pghealthindia.com/
- Phone
- +91 2262109000
- Auditors
- Haribhakti & Co. LLP
Upcoming Events for PGHL
Q4 2025 Procter & Gamble Health Ltd Earnings Release
Similar to PGHL
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Procter & Gamble Health share price?
As of Today at 22:44 UTC, shares in Procter & Gamble Health are trading at IN₹5,223.50. This share price information is delayed by 15 minutes.
How has the Procter & Gamble Health share price performed this year?
Shares in Procter & Gamble Health last closed at IN₹5,223.50 and the price had moved by +11.26% over the past 365 days. In terms of relative price strength the Procter & Gamble Health share price has outperformed the S&P BSE 100 Index by +3.09% over the past year.
What are the analyst and broker recommendations for Procter & Gamble Health?
The overall consensus recommendation for Procter & Gamble Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Procter & Gamble Health dividend yield?
The Procter & Gamble Health dividend yield is 2.68% based on the trailing twelve month period.
Does Procter & Gamble Health pay a dividend?
Last year, Procter & Gamble Health paid a total dividend of IN₹140.00, and it currently has a trailing dividend yield of 2.68%. We do not have any data on when Procter & Gamble Health is to next pay dividends.
When does Procter & Gamble Health next pay dividends?
We do not have data on when Procter & Gamble Health is to next pay dividends. The historic dividend yield on Procter & Gamble Health shares is currently 2.68%.
How do I buy Procter & Gamble Health shares?
To buy shares in Procter & Gamble Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Procter & Gamble Health?
As of the previous close price of IN₹5,223.50, shares in Procter & Gamble Health had a market capitalisation of IN₹86.71bn.
Where are Procter & Gamble Health shares listed?
Here are the trading details for Procter & Gamble Health:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: PGHL
What kind of share is Procter & Gamble Health?
Based on an overall assessment of its quality, value and momentum Procter & Gamble Health is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Procter & Gamble Health share price forecast for 2025?
The analyst consensus target price for shares in Procter & Gamble Health is IN₹5,235.00. That is 0.22% above the last closing price of IN₹5,223.50.
Analysts covering Procter & Gamble Health currently have a consensus Earnings Per Share (EPS) forecast of IN₹143.00 for the next financial year.
Find out moreWhat is the trend in the Procter & Gamble Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Procter & Gamble Health. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +3.54%.
As of the last closing price of IN₹5,223.50, shares in Procter & Gamble Health were trading -0.89% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Procter & Gamble Health PE Ratio?
The Procter & Gamble Health PE ratio based on its reported earnings over the past 12 months is 33.32. The shares last closed at IN₹5,223.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Procter & Gamble Health?
Procter & Gamble Health's management team is headed by:
- Suresh Talwar - NEC
- Amit Gupta - CFO
- Zeal Shah - CCO
- Vikas Gupta - GCN
- Milind Thatte - MDR
- Anand Nambiar - DRC
- Aalok Agrawal - NED
- Hon Keong Choo - NED
- Elizabeth Desmond - NED
- Bradley Simpson - NED
- Zoe Tang - NED
- Rani Jadhav - IND
- H. C. H. Bhabha - NID
- C. R. Dua - NID
- Subramanian Madhavan - NID